EFFECT OF MRIDHWIKADHI KASHAYA AND PANCHAGANDHA CHOORNAM THALAM IN THE MANAGEMENT OF PRIMARY HYPERTENSION
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Reduction in the blood pressure
研究概览
简要总结
Itis estimated that 17.6% of patient with primary hypertension globally live in india.the increased prevalence of hypertension and pre-hypertension among youngindians is being increasingly reported. there are high prevalence ofhypertension among indian adults, across all age groups. in addition there is apoor awareness, treatment and control among those with hypertension. also inmore than 95% of the cases specific underlying causes of hypertension is notfound. such patient are known to have primary hypertension.
Primaryhypertension accounts 90-95% of adult cases and 2-10% of them have secondarycause. in contemprory science anti-hypertension drug therapy using thiazide,β-adrenoceptor antagonists, calcium antagonists, vasodilators, angiotensionconverting hormone enzyme inhibitor drugs with or without combinations aregiven to combat hypertension. persistant usage of these drugs will lead to“resistance hypertension†which is followed by serious complications. thus to combat these hazardous steps, someeffective management are needed.
Hence this study isplanned to bring out effective managementof primary hypertension with administration of mridhwikadhi kashayam internallyand panchgandha choornam thalam externally
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 25.00 Year(s) 至 55.00 Year(s)(—)
- 性别
- All
入选标准
- •Cases with elevated systolic and diastolic blood pressure with possible complaints of Headache, dizziness , breathlessness, palpitation and insomnia
- •Diagnosed patients of primary hypertension willing to participate and sign the informed consent form will be selected for the study
- •Age between 25-55 4.all genders.
排除标准
- •1.Coronary artery diseases 2.Congestive heart failure 3.Pulmonary tuberculosis 4.Liver disorders 5.Kidney disorders 6.Spleen disorders 7.Diabetes mellitus & diabetes insipidus 8.Cardiac myopathies 9.Stage 2 hypertension 10.Malignant hypertension and secondary hypertension 11.Pregnant women 12.Patient under anti-hypertensive drugs, drugs- cortico-steroids 13.Patients with hereditary dispositions 14.Other systemic illness 15.Sleshma vikara rogi 16.Cervical pathologies.
结局指标
主要结局
Reduction in the blood pressure
时间窗: 28 Days
and symptoms such as headache, insomnia, dizziness, breathlessness and palpitation.
时间窗: 28 Days
次要结局
- Reduction in the blood pressure(and symptoms such as headache, insomnia, dizziness, breathlessness and palpitation.)
